Free press releases distribution network?

More news: Health/Surgery
Agency / Source: Channel PR

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



Rajiv Gandhi Cancer Institute & Research Center Brings New Technology in Cancer Management to India - Star Health Network, Inc. (Star) and Rajiv Gandhi Cancer Institute & Research Center (RGCI&RC) are proud to announce the availability of molecular Tumor Profiling (TP) tests from the Yale School of Medicine and Thomas Jefferson University, USA
Rajiv Gandhi Cancer Institute & Research Center Brings New Technology in Cancer Management to India

 

PRZOOM - /newswire/ - New Delhi, Delhi, India, 2013/12/02 - Star Health Network, Inc. (Star) and Rajiv Gandhi Cancer Institute & Research Center (RGCI&RC) are proud to announce the availability of molecular Tumor Profiling (TP) tests from the Yale School of Medicine and Thomas Jefferson University, USA.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

RGCI&RC is the first Indian cancer hospital to offer this new cancer detection technology, which provides the genomic information on a patient's tumor and advances the delivery of high quality of personalized precision medicine. Precision Medicine is the tailoring of medical treatment according to the unique genetic profile of each patient's tumor.

Tumor profiling help search out that genetic alteration which is driving the growth of tumor and can possibly be targeted with the available targeted molecule or by molecules in clinical trials and pipeline. TP tests are currently available for Lung, Breast, Biliary Tract (Pancreas, Bile Duct, Gallbladder) Ovarian, Thyroid, Colorectal & Urinary Tract cancers and Acute Leukemia & Melanoma. TP tests are tailored from eight genes most likely to be altered in these common cancers. TP tests detect 69 actionable mutations, meaning there are approved drugs or drugs in clinical trials that can target these specific mutations.

For Indian cancer patients the process is simple: world-class pathologists at Yale School of Medicine & Thomas Jefferson University perform high throughput genotyping analysis of a patient's tumor DNA and provide a report within 10-15 days. Oncologists at RGCI&RC or your center can then match the genomic profile of your tumor to available drugs or drugs in clinical trials. This personalized approach of targeted therapy could result in many more patients receiving only those drugs that are known to work specifically for their kind of cancer. "Having a targeted therapy to a cancer mutation can reduce the need for chemotherapy, which is associated with debilitating side effects," said Dr. John Sanil Manavalan, Chief Medical Officer of Star.

Dr. Mehta, Chief of Pathology at RGCI&RC, recently visited Yale and Thomas Jefferson University and other Star partner institutions in the United States, to obtain first hand exposure to this unique TP technology. He says,"This is a beginning of a revolution and is a big step in advancing precision medicine in cancer. We have launched a national awareness campaign to help physicians and patients understand how TP tests can be effective in cancer care. This is the result of our partnership with leaders like Star, and its network of U.S. institutions, in all areas of clinical oncology and cancer genomics; partners who are equally committed to the changing the paradigm of cancer care".

"Overall, cancer genetic profiling is revolutionizing the way cancers are treated. Star and its U.S. institutional partners are the first to bring this cutting edge technology to India with RGCI&RC as its partner. All patients who have cancer or have been recently diagnosed with cancer should consult their treating oncologists to take advantage of the availability of these tests at RGCI&RC," said Dr. Jamal Naiyer, President and CEO of Star.

Mr. David McCallen spokesperson and Chief Marketing Officer of Star provides a high level analysis: "While India has made tremendous progress in healthcare delivery over the past decade, it is still behind in leading edge diagnostics and research. Our priority is to bridge these gaps by providing access to world-class healthcare institutions and their innovations: these tests from the Yale School of Medicine are a perfect, real world example of how our network can positively impact patients, doctors and hospitals worldwide.”

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Health/Surgery Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: Channel PR

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Health/Surgery articles,
CATCH Visitors via Your Competitors Announcements!


Rajiv Gandhi Cancer Institute & Research Center Brings New Technology in Cancer Management to India

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Prasoon - ChannelPR.in 
+91 98 71744743 info[.]channelpr.in
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Channel PR securities in any jurisdiction including any other companies listed or named in this release.

Health/Surgery via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From Channel PR / Company Profile


Read Health/Surgery Most Recent Related Press Releases:

Persistence Market Research Publishes Traditional Chinese Medicine Market Forecast Over 2017-2025
Inferior Vena Cava Filters Market to Register A Strong Growth by 2025 Notes Persistence Market Research
Plasma Component Separator Market Set to Surge Significantly During 2017-2025 Says PMR
Persistence Market Research Releases Fertility Enhancing Treatment Market Snapshot by 2017-2025
Cardiac Biomarkers Market Expected to Generate Huge Profits by 2017-2025 Reports PMR
Stone Management System Market Foreseen to Grow Exponentially Over 2017-2025 Finds PMR
Global Hemoglobinopathy Market Worth US$ 788M by 2024 According to Persistence Market Research
Dentsu Announces its Corporate Venture Capital Fund Dentsu Ventures Investment in Grail
Xenex Receives Top Honors from Frost & Sullivan for LightStrike™ - the Only Pulsed Xenon UV Disinfection System in the Healthcare Market
Partners HealthCare and GE Healthcare Launch 10-year Collaboration to Integrate Artificial Intelligence into Every Aspect of the Patient Journey

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  BizJobs.com

Visit RightITnow Ltd

Visit  MagLar, Inc.







 
  ©2017 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today